IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Karl-Georg Metzger

USPTO Granted Patents = 20

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 122(Granted Patents)


Location History:

  • Wuppertal-Elberfeld, DE (1976 - 1977)
  • Wuppertal, DE (1976 - 1997)

Company Filing History:

goldMedal20 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1976-1997

Loading Chart...
20 patents (USPTO):Explore Patents
1. 5679675 - 8-amino-10-(azabicycloalkyl)-pyrido�1,2,3-d,e!�1,3,4!benzoxadiazine (1997-10-21),
2. 5480879 - Quinolonecarboxylic acids (1996-01-02),
3. 5464796 - 7-isoindolinyl-quinolone-carboxylic acid derivatives (1995-11-07),
4. 5457104 - Quinolone- and naphthyridonecarboxylic acid derivatives (1995-10-10),
5. 5371090 - Naphthyridonecarboxylic acid derivatives (1994-12-06),
6. 5324721 - 3-Substituted cephalosporins, and their use as medicaments (1994-06-28),
7. 5312823 - 7-azaisoindolinyl-quinolone-carboxylic acid derivatives (1994-05-17),
8. 4686208 - Phosphorylated glycosyl-amides, -ureas, -carbamates and -thiocarbamates (1987-08-11),
9. 4235888 - Pseudotrissaccharides, a process for their production and their use as (1980-11-25),
10. 4199572 - N-Substituted amino glycoside compounds, their production, and their use (1980-04-22),
11. 4009272 - Penicillins (1977-02-22),
12. 3993770 - Penicillins (1976-11-23),
13. 3993642 - Penicillins (1976-11-23),
14. 3978056 - Penicillins (1976-08-31),
15. 3975375 - Penicillins (1976-08-17),

Title: Insights into the Innovations of Karl-Georg Metzger

Introduction

Karl-Georg Metzger, a prolific inventor based in Wuppertal, Germany, has made significant contributions to the field of antibacterial compositions through his innovative patents. With a remarkable portfolio of 20 patents, Metzger continues to push the boundaries of modern medicine, particularly in the development of new pharmaceutical agents.

Latest Patents

Among his latest innovations, Metzger has developed a patent for 8-amino-10-(azabicycloalkyl)-pyrido[1,2,3-d,e][1,3,4]benzoxadiazine. This invention relates to novel derivatives of this chemical compound which hold potential applications in antibacterial treatments. The patent outlines the general formula of these derivatives and describes their preparation processes and usage in developing effective antibacterial compositions.

Another significant patent focuses on quinolonecarboxylic acids. Metzger's research here explores novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid, which are interconnected with beta-lactam antibiotics. This innovation highlights new salts, preparation methods, and their potential as antibacterial agents.

Career Highlights

Karl-Georg Metzger's career is marked by his association with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer reflects a strong commitment to research and innovation, specifically in the area of pharmaceuticals that combat bacterial infections.

Collaborations

Throughout his career, Metzger has collaborated with esteemed colleagues such as Wilfried Schrock and Hans-Bodo König. These partnerships have undoubtedly contributed to the intricate research processes and innovative outcomes of their combined efforts.

Conclusion

In conclusion, Karl-Georg Metzger stands out in the world of innovation with his extensive patent portfolio and significant contributions to antibacterial research. His work not only showcases the potential of modern pharmaceuticals but also emphasizes the importance of collaboration in achieving groundbreaking advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…